AzTrials
AzTrials

SciaticaHiatUSNCT02897336

Ultrasound-guided Caudal or Interlaminar Corticosteroid Epidural Injection for Sciatica

A study testing ultrasound-guided and interlaminar in people with Sciatica, run by University Hospital, Caen at 1 site in France.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

An open-label randomized trial to compare the efficacy of ultrasound-guided caudal and interlaminar corticosteroid injections for the treatment of lumbar disk herniation-related sciatica. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Sciatica
What is being tested?
ultrasound-guided and interlaminar
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteFrance
Study dates
Jul 2016to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • radicular pain (sciatica or cruralgia) for more than 2 weeks
  • failure of analgesics and NSAIDs
  • without neurological deficiency (motor weakness lower or equal to 3/5)
  • a lumbar disk herniation on MRI or CT dating less than 3 months

Who cannot join

  • history of lumbar surgery
  • history of epidural injection during the last 3 months
  • radicular pain not due to disk herniation
  • a contraindication to epidural injection (infection, diabetes)
  • history of allergic reaction to corticosteroid
  • patient under legal guardianship

Trial locations and contacts

1 site in 1 country.

France1 site
  • University Hospital

    Caen, 14000

Other trials in France

About this study

Official title: Ultrasound-guided Caudal or Interlaminar Injection? A Comparative Study of Epidural Corticosteroid Injections in the Treatment of Lumbar Disk Herniation-related Sciatica

An open-label randomized trial to compare the efficacy of ultrasound-guided caudal and interlaminar corticosteroid injections for the treatment of lumbar disk herniation-related sciatica.

Read the detailed description

An open-label randomized trial conducted in one centre to compare the efficacy of ultrasound-guided caudal and interlaminar corticosteroid injections for the treatment of lumbar disk herniation-related sciatica. 30 male and female patients will be included in each group. The primary outcome measure will be a 30% decrease in lower limbs pain as assessed by a visual analog scale.

Conditions
Sciatica
Being tested
ultrasound-guided, interlaminar
Medical subject headings
Sciatica

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ultrasound-guidedProcedure or surgery

    ultrasound-guided caudal epidural corticosteroid injection

  • interlaminarProcedure or surgery

    interlaminar epidural corticosteroid injection

Study groups in NCT02897336
Study groupRoleWhat they receive
ultrasound-guidedExperimentalultrasound-guided caudal epidural corticosteroid injection
Receives: Procedure: ultrasound-guided
interlaminarActive comparatorinterlaminar epidural corticosteroid injection
Receives: Procedure: interlaminar

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. lower limbs pain

    a 30% decrease in lower limbs pain using a visual analog scale

    Measured: day 15

Secondary outcomes (7)
  1. Oswestry questionnaire

    low back pain disability assessment using Oswestry questionnaire

    Measured: day 15 - month 1 - month 3 - month 6

  2. A decrease of radicular pain with a pain numerical scale lower or equal to 3/10

    pain numerical scale lower or equal to 3/10

    Measured: day 15 - month 1 - month 3 - month 6

  3. neurological deficiency assessed by neurological examination

    motor weakness or sensitive deficiency in lower limbs

    Measured: day 15 - month 1 - month 3 - month 6

  4. drugs

    decrease in analgesic treatment

    Measured: day 15 - month 1 - month 3 - month 6

  5. medical outcome

    Medical Outcome study Short Form (SF-36)

    Measured: day 15 - month 1 - month 3 - month 6

  6. resumption of work

    deadline of resumption of work

    Measured: day 15 - month 1 - month 3 - month 6

  7. number of patients with treatment-related adverse events as assessed by CTCAE v4.0

    adverse events assessed by CTCAE v4.0

    Measured: day 15 - month 1 - month 3 - month 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Sep 2016 (estimated)
  2. Study startJul 2016
  3. Primary completionDec 2017
  4. Study completionDec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02897336
Sponsor's protocol ID
2015-A01502-47
Acronym
HiatUS
Status last verified
Jan 2020
First submitted
31 Aug 2016
Last updated
31 Jan 2020
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing ultrasound-guided and interlaminar in people with Sciatica, run by University Hospital, Caen at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 31 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

lower limbs pain (time frame: day 15). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in